Bhagyashri Navalkele

Bhagyashri Navalkele practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Bhagyashri Navalkele's NPI, 1427474915, was assigned on March 9, 2014. Bhagyashri Navalkele holds Georgia license 99473.

Bhagyashri Navalkele's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Bhagyashri Navalkele's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. The medical group on file is Emory Clinic. Dmand AI also links Bhagyashri Navalkele to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bhagyashri Navalkele practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Bhagyashri Navalkele's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Bhagyashri Navalkele's licenses on file in 2 states: Georgia and Mississippi.

CMS data shows 95 Medicare services from Bhagyashri Navalkele across 2 procedure codes in 2024, for 73 Medicare patients. Medicare paid $10,048 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Bhagyashri Navalkele in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Bhagyashri Navalkele's median patient age at 67, with 40% women.

In 2024, Bhagyashri Navalkele wrote 209 Medicare Part D claims for 32 patients. 55% of them were for generic drugs. CMS names the drug for 86 of them, across 4 drugs with 11 or more claims each, at $233,887 in total drug cost. In 2023, CMS named 100 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Bhagyashri Navalkele for performance year 2024, reported through an alternative payment model (APM). Bhagyashri Navalkele accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Bhagyashri Navalkele as offering telehealth.

CMS Open Payments shows 7 general payments to Bhagyashri Navalkele from 4 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 55% of the total. Xellia Pharmaceuticals paid the most, $1,867.